251
Views
0
CrossRef citations to date
0
Altmetric
Articles

New chromone analog and pyrrole alkaloid produced by Penicillium sclerotiorum and their antibacterial activity

, , , &
Pages 225-230 | Received 21 Feb 2022, Accepted 04 May 2022, Published online: 21 Jun 2022
 

Abstract

A new chromone analog (1) and a new pyrrole alkaloid (2), together with four known compounds, were isolated from the endophytic fungus Penicillium sclerotiorum MPT-250 obtained from the stems of Taxus wallichiana var. chinensis (Pilger) Florin. The structural elucidation of these metabolites was performed by high-resolution mass spectrometry and NMR spectroscopy. Compounds 1 and 5 exhibited significant antibacterial activity against carbapenems-resistant Pseudomonas aeruginosa and multidrug-resistant Enterococcus faecium with an minimum inhibitory concentration (MIC) value of 3.13 μg/ml respectively.

Graphical Abstract

Disclosure statement

Authors declare no conflict of interest.

Additional information

Funding

This work was financially supported by the National Natural Science Foundation of China (Nos. 81872755, 82073714, and 31900288), the National Key R&D Program of China (2020YFC1712703), the National Civil Affairs Commission´s young and middle-aged talents training program (MZR20008), the Fundamental Research Funds for the Central Universities, South-Central University for Nationalities (YZZ20009), the Key Project at Central Government Level: The ability establishment of sustainable use for valuable Chinese medicine resources (2060302), and the Fundamental Research Funds for the Provincial Universities of Zhejiang (2021TD001).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.